腸骨ステントの世界市場レポート 2025年

腸骨ステント市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.9％で14億3,000万米ドルに成長します。予測期間の成長は、末梢動脈疾患の有病率の増加、老年人口の増加、血管形成術の増加、より侵襲の少ない手術の必要性の上昇、糖尿病の罹患率の上昇などに起因します。予測期間における主な動向には、腸骨ステントの技術的進歩、製品承認の増加、医療技術の進歩、流通網の拡大、外来患者への腸骨ステントの採用などがあります。

末梢動脈疾患の罹患率の増加が、当面の腸骨ステント市場の拡大を牽引すると予測されます。末梢動脈疾患（PAD）は、心臓や脳以外の動脈の狭窄や閉塞を特徴とする血管疾患で、多くの場合、喫煙、高齢化、高血圧、糖尿病などの要因に起因します。腸骨ステント留置術はPAD患者にとって貴重な治療法として登場し、血流の改善、症状の緩和、合併症の軽減をもたらすが、そのすべてが低侵襲で高い成功率を誇っています。例えば、2023年7月の心血管造影・インターベンション学会のデータによると、PADは毎年800万～1,000万人のアメリカ人を罹患させ、2050年には1,900万人のアメリカ人がPADに罹患すると予測されています。したがって、末梢動脈疾患の有病率の上昇は、腸骨ステント市場の原動力となっています。

腸骨ステント市場の主要プレーヤーは、患者の予後を改善し、合併症の可能性を減少させるために、iCastのような製品の革新に専念しています。iCastで覆われたステントシステムは、腸骨動脈閉塞性疾患に対処する新しいアプローチを意味し、従来のベアメタルステントと比較して優れた性能と合併症リスクの低減を提供します。例えば、2023年10月、Getinge社は、腸骨動脈閉塞性疾患の治療用としてFDAの承認を受けたiCast-coveredステントシステムの米国での市販を発表しました。この開発は、米国の臨床医や病院システムに対して、この重大な疾患を効果的に管理するためのトップクラスの製品とサポートを提供するというGetinge社のコミットメントを強調するものです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界腸骨ステント PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の腸骨ステント市場：成長率分析
• 世界の腸骨ステント市場の実績：規模と成長, 2019-2024
• 世界の腸骨ステント市場の予測：規模と成長, 2024-2029, 2034F
• 世界腸骨ステント総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の腸骨ステント市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 自己拡張型ステント
• バルーン拡張型ステント
• その他のタイプ
• 世界の腸骨ステント市場動脈病変による、実績と予測, 2019-2024, 2024-2029F, 2034F
• 総腸骨動脈病変
• 重度の石灰化病変
• 完全閉塞性病変
• 世界の腸骨ステント市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 外来施設
• その他のエンドユーザー
• 世界の腸骨ステント市場自己拡張型ステントの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ニチノール自己拡張型ステント
• ポリマーコーティング自己拡張型ステント
• 世界の腸骨ステント市場バルーン拡張型ステントの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ベアメタルバルーン拡張型ステント
• 薬剤溶出バルーン拡張型ステント
• 世界の腸骨ステント市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• カバー付きステント
• ハイブリッドステント

第7章 地域別・国別分析

• 世界の腸骨ステント市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の腸骨ステント市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 腸骨ステント市場：競合情勢
• 腸骨ステント市場：企業プロファイル
  • Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
  • Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• B. Braun Melsungen AG
• Terumo Corporation
• W. L. Gore & Associates Inc
• C. R. Bard Inc.
• Getinge AB
• Cook Medical LLC
• Biotronik SE & Co. KG
• MicroPort Scientific Corporation
• Cordis Corporation
• Endologix Inc.
• LeMaitre Vascular Inc.
• Alvimedica
• Clearstream Technologies Ltd.
• Jotec GmbH
• Translumina GmbH

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 腸骨ステント市場2029：新たな機会を提供する国
• 腸骨ステント市場2029：新たな機会を提供するセグメント
• 腸骨ステント市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Iliac stents are specialized medical devices crafted to address atherosclerosis in the iliac arteries, situated in the pelvic region. These stents are deployed through minimally invasive procedures such as angioplasty to widen and provide support to narrowed or obstructed arteries.

The primary types of iliac stents include self-expandable stents, balloon-expandable stents, and others. Self-expandable stents are medical instruments utilized for treating narrowed or obstructed blood vessels in various parts of the body, including the coronary arteries, peripheral arteries, and other tubular structures. They are employed in the treatment of various artery lesions such as common iliac artery lesions, severe calcified lesions, and complete obstructive lesions. These stents are utilized by a range of end-users including hospitals, outpatient facilities, and others.

The iliac stent market research report is one of a series of new reports from The Business Research Company that provides iliac stent market statistics, including iliac stent industry global market size, regional shares, competitors with an iliac stent market share, detailed iliac stent market segments, market trends, and opportunities, and any further data you may need to thrive in the iliac stent industry. This iliac stent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The iliac stent market size has grown strongly in recent years. It will grow from $1.02 billion in 2024 to $1.09 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to expansion of the global healthcare industry, increased awareness about minimally invasive procedures, increased demand for stenting procedures, rise in incidence of iliac artery diseases, improved healthcare infrastructure.

The iliac stent market size is expected to see strong growth in the next few years. It will grow to $1.43 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to increasing prevalence of peripheral artery diseases, growing geriatric population, increasing angioplasty operations, rise in the need for less intrusive operations, rising incidence of diabetes. Major trends in the forecast period include technological advancements in iliac stents, increasing number of product approvals, advancements in medical technology, expanding distribution networks, adoption of iliac stents in outpatient settings.

The increasing incidence of peripheral artery diseases is anticipated to drive the expansion of the iliac stent market in the foreseeable future. Peripheral artery disease (PAD) is a vascular condition characterized by the narrowing or blockage of arteries outside the heart and brain, often attributed to factors such as smoking, an aging population, hypertension, and diabetes. Iliac stenting emerges as a valuable treatment modality for PAD patients, offering enhanced blood flow, relief from symptoms, and mitigation of complications, all while being minimally invasive and boasting a high success rate. For instance, as per data from the Society for Cardiovascular Angiography and Interventions in July 2023, PAD affects 8-10 million Americans annually, with projections estimating 19 million Americans to be affected by PAD by 2050. Hence, the escalating prevalence of peripheral artery diseases serves as a driving force for the iliac stent market.

Key players in the iliac stent market are dedicated to innovating products such as iCast to elevate patient outcomes and diminish the likelihood of complications. The iCast-covered stent system signifies a novel approach to addressing iliac artery occlusive disease, offering superior performance and a reduced risk of complications compared to conventional bare-metal stents. For instance, in October 2023, Getinge announced the US commercial availability of the iCast-covered stent system, FDA-approved for treating iliac arterial occlusive disease. This development underscores Getinge's commitment to furnishing US clinicians and hospital systems with top-tier products and support for managing this critical condition effectively.

In February 2023, Abbott Laboratories finalized the acquisition of Cardiovascular Systems Inc. (CSI) for an undisclosed sum. This strategic move by Abbott Laboratories aims to enrich its vascular device portfolio by integrating CSI's innovative atherectomy system. Cardiovascular Systems Inc. is renowned for its contributions in the realm of medical technology, particularly in manufacturing iliac stents.

Major companies operating in the iliac stent market are Cardinal Health Inc., Abbott Laboratories, Medtronic Plc, Becton, Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, W. L. Gore & Associates Inc, C. R. Bard Inc., Getinge AB, Cook Medical LLC, Biotronik SE & Co. KG, MicroPort Scientific Corporation, Cordis Corporation, Endologix Inc., LeMaitre Vascular Inc., Alvimedica, Clearstream Technologies Ltd., Jotec GmbH, Translumina GmbH, Vascular Concepts Limited, Lombard Medical Technologies, Acandis GmbH, Gore Medical, Medizintechnik GmbH

North America was the largest region in the iliac stent market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the iliac stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the iliac stent market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The iliac stents market consists of sales of coronary stents, biliary stents, and ureteral stents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Iliac Stent Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on iliac stent market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for iliac stent ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The iliac stent market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Self-Expandable Stents; Balloon-Expandable Stents; Other Types
• 2) By Artery Lesions: Common Iliac Artery Lesions; Severe Calcified Lesions; Complete Obstructive Lesions
• 3) By End-Users: Hospitals; Outpatient Facilities; Other End-Users
• Subsegments:
• 1) By Self-Expandable Stents: Nitinol Self-Expandable Stents; Polymer-Coated Self-Expandable Stents
• 2) By Balloon-Expandable Stents: Bare-Metal Balloon-Expandable Stents; Drug-Eluting Balloon-Expandable Stents
• 3) By Other Types: Covered Stents; Hybrid Stents
• Companies Mentioned: Cardinal Health Inc.; Abbott Laboratories; Medtronic Plc; Becton, Dickinson and Company; Boston Scientific Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Iliac Stent Market Characteristics

3. Iliac Stent Market Trends And Strategies

4. Iliac Stent Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Iliac Stent Growth Analysis And Strategic Analysis Framework

• 5.1. Global Iliac Stent PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Iliac Stent Market Growth Rate Analysis
• 5.4. Global Iliac Stent Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Iliac Stent Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Iliac Stent Total Addressable Market (TAM)

6. Iliac Stent Market Segmentation

• 6.1. Global Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Self-Expandable Stents
• Balloon-Expandable Stents
• Other Types
• 6.2. Global Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Common Iliac Artery Lesions
• Severe Calcified Lesions
• Complete Obstructive Lesions
• 6.3. Global Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Outpatient Facilities
• Other End-Users
• 6.4. Global Iliac Stent Market, Sub-Segmentation Of Self-Expandable Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nitinol Self-Expandable Stents
• Polymer-Coated Self-Expandable Stents
• 6.5. Global Iliac Stent Market, Sub-Segmentation Of Balloon-Expandable Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bare-Metal Balloon-Expandable Stents
• Drug-Eluting Balloon-Expandable Stents
• 6.6. Global Iliac Stent Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Covered Stents
• Hybrid Stents

7. Iliac Stent Market Regional And Country Analysis

• 7.1. Global Iliac Stent Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Iliac Stent Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Iliac Stent Market

• 8.1. Asia-Pacific Iliac Stent Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Iliac Stent Market

• 9.1. China Iliac Stent Market Overview
• 9.2. China Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Iliac Stent Market

• 10.1. India Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Iliac Stent Market

• 11.1. Japan Iliac Stent Market Overview
• 11.2. Japan Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Iliac Stent Market

• 12.1. Australia Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Iliac Stent Market

• 13.1. Indonesia Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Iliac Stent Market

• 14.1. South Korea Iliac Stent Market Overview
• 14.2. South Korea Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Iliac Stent Market

• 15.1. Western Europe Iliac Stent Market Overview
• 15.2. Western Europe Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Iliac Stent Market

• 16.1. UK Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Iliac Stent Market

• 17.1. Germany Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Iliac Stent Market

• 18.1. France Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Iliac Stent Market

• 19.1. Italy Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Iliac Stent Market

• 20.1. Spain Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Iliac Stent Market

• 21.1. Eastern Europe Iliac Stent Market Overview
• 21.2. Eastern Europe Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Iliac Stent Market

• 22.1. Russia Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Iliac Stent Market

• 23.1. North America Iliac Stent Market Overview
• 23.2. North America Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Iliac Stent Market

• 24.1. USA Iliac Stent Market Overview
• 24.2. USA Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Iliac Stent Market

• 25.1. Canada Iliac Stent Market Overview
• 25.2. Canada Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Iliac Stent Market

• 26.1. South America Iliac Stent Market Overview
• 26.2. South America Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Iliac Stent Market

• 27.1. Brazil Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Iliac Stent Market

• 28.1. Middle East Iliac Stent Market Overview
• 28.2. Middle East Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Iliac Stent Market

• 29.1. Africa Iliac Stent Market Overview
• 29.2. Africa Iliac Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Iliac Stent Market, Segmentation By Artery Lesions, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Iliac Stent Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Iliac Stent Market Competitive Landscape And Company Profiles

• 30.1. Iliac Stent Market Competitive Landscape
• 30.2. Iliac Stent Market Company Profiles
  • 30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Iliac Stent Market Other Major And Innovative Companies

• 31.1. B. Braun Melsungen AG
• 31.2. Terumo Corporation
• 31.3. W. L. Gore & Associates Inc
• 31.4. C. R. Bard Inc.
• 31.5. Getinge AB
• 31.6. Cook Medical LLC
• 31.7. Biotronik SE & Co. KG
• 31.8. MicroPort Scientific Corporation
• 31.9. Cordis Corporation
• 31.10. Endologix Inc.
• 31.11. LeMaitre Vascular Inc.
• 31.12. Alvimedica
• 31.13. Clearstream Technologies Ltd.
• 31.14. Jotec GmbH
• 31.15. Translumina GmbH

32. Global Iliac Stent Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Iliac Stent Market

34. Recent Developments In The Iliac Stent Market

35. Iliac Stent Market High Potential Countries, Segments and Strategies

• 35.1 Iliac Stent Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Iliac Stent Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Iliac Stent Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer